Tapering Lurasidone (Latuda) to Risperidone (Risperdal)
Yes, you can taper Latuda to Risperdal using a gradual cross-tapering approach to minimize withdrawal symptoms and maintain symptom control. 1
Cross-Tapering Protocol
- Begin with a slow, reasonable, collaborative taper with adjuvant treatments as needed for withdrawal symptoms 2
- Avoid abrupt discontinuation of Latuda, as sudden cessation of antipsychotics is considered unacceptable medical care 2
- Follow this specific cross-tapering schedule:
Week 1-2:
- Continue full dose of Latuda while starting Risperidone at a low dose (0.5-1mg daily) 1, 3
- This overlap period helps prevent withdrawal symptoms and maintains symptom control 3
Week 3-4:
Week 5-6:
- Reduce Latuda by another 25% 4
- Adjust Risperidone to target therapeutic dose (typically 4-6mg daily) 1
Week 7-8:
Monitoring During Transition
- Schedule regular follow-up appointments (every 2-4 weeks) to assess for:
Managing Potential Challenges
- If withdrawal symptoms occur during tapering, consider temporarily returning to the previous dose before attempting a more gradual reduction 2
- If side effects from Risperidone emerge, slow the upward titration while continuing the Latuda taper 1
- For patients experiencing difficulty with the transition, extending the overlap period between medications may be beneficial 3
Important Considerations
- Document baseline symptoms and functioning before initiating the taper 1
- Percentage reductions should not be understood as a straight-line taper; each new dose should be a percentage of the previous dose 2
- Be prepared to adjust the tapering schedule based on the individual patient's response 1
- Consider adjunctive medications to manage specific withdrawal symptoms if they occur 1
Common Pitfalls to Avoid
- Abrupt discontinuation of Latuda, which can trigger withdrawal symptoms 2
- Starting Risperidone at full therapeutic dose while still on higher doses of Latuda, which increases risk of adverse effects 4
- "Cold referrals" to clinicians who have not agreed to accept the patient during medication transitions 2
- Failing to monitor for both withdrawal symptoms and potential side effects of the new medication 1